NCT03528941 2022-05-12
LLC1618
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
Clinical Trials
7 trialsNCT02186574 2019-12-12
Tenofovir to Prevent HBV Reactivation
University Health Network, Toronto
Phase 3 Unknown
NCT01311232 2017-10-27
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
Samsung Medical Center
Completed
NCT01765231 2017-01-10
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Peking University
Phase 4 Unknown
NCT01768195 2017-01-10
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Peking University
Phase 4 Unknown
NCT02108444 2014-07-24
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
Peking University
Completed
NCT00926757 2013-05-29
HBVNHL
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed